Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Understanding the Inflammatory Cytokine Response.

Slides:



Advertisements
Similar presentations
 Exemplary Care  Cutting-edge Research  World-class Education  Raghavan Murugan MD, MS, FRCP Associate Professor Dept. of Critical Care Medicine Clinical.
Advertisements

Date of download: 5/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Comparative Effectiveness of Rhythm Control vs Rate.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Serum Creatinine Is an Inadequate Screening Test.
Date of download: 5/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Risk of Mortality and End-Stage Renal Disease.
Date of download: 5/29/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Adjuvant Chemotherapy With Gemcitabine and Long-term.
Date of download: 6/1/2016 Copyright © The American College of Cardiology. All rights reserved. From: Mortality and Cardiovascular Events Are Best Predicted.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Similar Outcomes With Hemodialysis and Peritoneal.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Efficacy of Omeprazole for the Treatment of Symptomatic.
Date of download: 6/2/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effectiveness of Foot Orthoses to Treat Plantar Fasciitis:
Date of download: 6/3/2016 Copyright © The American College of Cardiology. All rights reserved. From: Incidence, Temporal Trends, and Prognostic Impact.
Date of download: 6/3/2016 From: Elevated Plasma Homocysteine Level Is an Independent Predictor of Coronary Heart Disease Events in Patients with Type.
Date of download: 6/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The Growing Burden of Tuberculosis: Global Trends.
Date of download: 6/22/2016 From: Biomarkers of Inflammation and Thrombosis as Predictors of Near-Term Mortality in Patients with Peripheral Arterial Disease:
Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: National Trends in Ambulatory Visits and Antibiotic.
Date of download: 6/24/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Long-term Prognosis of Acute Kidney Injury After.
Date of download: 6/24/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Use of a Blood Glucose Monitoring Manual to Enhance.
Date of download: 6/24/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Interleukin 6 and Interleukin 8 as Potential Biomarkers.
Date of download: 6/25/2016 Copyright © 2016 American Medical Association. All rights reserved. From: The Colorado Thyroid Disease Prevalence Study Arch.
Date of download: 6/25/2016 From: Blood Pressure and Mortality in U.S. Veterans With Chronic Kidney Disease: A Cohort Study Ann Intern Med. 2013;159(4):
Date of download: 6/26/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Trends in Anemia Care in Older Patients Approaching.
Date of download: 6/27/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Reference Values for Self-recorded Blood Pressure:
Date of download: 6/28/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Impact of Influenza Vaccination on Seasonal Mortality.
Date of download: 6/28/2016 Copyright © The American College of Cardiology. All rights reserved. From: Prevalence and Clinical Implications of Newly Revealed,
Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Fibroblast Growth Factor 23 and Risks of Mortality.
Date of download: 7/3/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Extended Hypermetabolic Response of the Liver in Severely.
Date of download: 7/5/2016 Copyright © 2016 American Medical Association. All rights reserved. From: A Prognostic Risk Index for Long-term Mortality in.
Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Association Between Apple Consumption and Physician.
Date of download: 7/6/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Effect of Antiretroviral Therapy on Viral Load, CD4.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Antiarrhythmic Drugs for Maintaining Sinus Rhythm.
Date of download: 7/7/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Corticosteroids in the Treatment of Severe Sepsis.
Date of download: 7/8/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Troponin Criteria for Myocardial Infarction After.
Date of download: 7/9/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Development of Antidrug Antibodies Against Adalimumab.
Date of download: 7/10/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Variation in Use of Dual-Chamber Implantable Cardioverter-Defibrillators:
Date of download: 9/17/2016 From: Plasma Cytokine and Endotoxin Levels Correlate with Survival in Patients with the Sepsis Syndrome Ann Intern Med. 1993;119(8):
Date of download: 9/17/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Clinical and Epidemiologic Features of Group A Streptococcal.
Date of download: 11/12/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Independent Components of Chronic Kidney Disease.
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2005 American Medical Association. All rights reserved.
Ann Intern Med. 2016;164(8): doi: /M Figure Legend:
Copyright © 2000 American Medical Association. All rights reserved.
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2005 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2012 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2001 American Medical Association. All rights reserved.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2006 American Medical Association. All rights reserved.
Copyright © 2003 American Medical Association. All rights reserved.
Copyright © 2006 American Medical Association. All rights reserved.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 1998 American Medical Association. All rights reserved.
Copyright © 2004 American Medical Association. All rights reserved.
Copyright © 2010 American Medical Association. All rights reserved.
Copyright © 2010 American Medical Association. All rights reserved.
From: Long-Term Outcome of Anti–Glomerular Basement Membrane Antibody Disease Treated with Plasma Exchange and Immunosuppression Ann Intern Med. 2001;134(11):
Copyright © 2011 American Medical Association. All rights reserved.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2006 American Medical Association. All rights reserved.
Copyright © 2008 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2007 American Medical Association. All rights reserved.
Copyright © 2001 American Medical Association. All rights reserved.
Copyright © 2009 American Medical Association. All rights reserved.
Copyright © 2004 American Medical Association. All rights reserved.
Copyright © 2013 American Medical Association. All rights reserved.
Figure 2. Odds ratios (ORs) from the multivariate logistic regression analysis and hazard ratios (HRs) from the Cox regression analysis Odds ratios (ORs)
Presentation transcript:

Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med. 2007;167(15): doi: /archinte Subject disposition for the entire Genetic and Inflammatory Markers of Sepsis (GenIMS) cohort. CAP indicates community-acquired pneumonia. Figure Legend:

Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med. 2007;167(15): doi: /archinte Mortality rates for subjects with community-acquired pneumonia with and without sepsis. Severe sepsis was defined as sepsis with organ failure (Sepsis-related Organ Failure Assessment score ≥3 in any organ system). Figure Legend:

Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med. 2007;167(15): doi: /archinte Mean plasma cytokine concentrations (A) and proportion of subjects with community-acquired pneumonia (CAP) with elevated plasma concentrations (B). IL-6 indicates interleukin 6; ln, natural log; and TNF, tumor necrosis factor. A, Mean (ln) plasma cytokine concentrations for subjects with CAP by outcome and over time. B, Percentage of subjects with CAP with elevated concentrations compared with the normal range for each molecule by outcome. Elevated was defined for IL-6 as greater than 5.9 pg/mL; for IL-10, greater than 9.1 pg/mL; and for TNF, greater than 8.1 pg/mL. Figure Legend:

Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med. 2007;167(15): doi: /archinte Patterns of cytokine response to infection and resulting patterns of outcomes. A, Trajectory analysis of IL-6 (interleukin 6) and IL-10 concentration data suggests 3 distinct patterns of cytokine response during the first 7 days in the hospital. Combinations of 1, 2, 3, or 4 groups with quadratic, cubic, or linear trends of the cytokine levels, irrespective of outcome, were analyzed. For both IL-6 and IL-10, 3-group models (high, medium, and low cytokine concentration) with a quadratic trend for each group exhibited the best fit. ln Indicates natural log. B (top), The Kaplan-Meier analysis includes survival curves that represent different combinations of the IL-6/IL- 10 cytokine responses. Although there are 9 such combinations, some groups have been collapsed together because of similar survival rates. Five distinct patterns of outcome were observed. The numbers of subjects in each group are as follows: low IL-6, n = 667 (35.4%); medium IL-6, n = 1003 (53.2%); high IL-6, n = 216 (11.4%); low IL-10, n = 1255 (65%); medium IL-10, n = 509 (27%); and high IL-10, n = 152 (8%). Figure Legend:

Date of download: 6/23/2016 Copyright © 2016 American Medical Association. All rights reserved. From: Understanding the Inflammatory Cytokine Response in Pneumonia and Sepsis: Results of the Genetic and Inflammatory Markers of Sepsis (GenIMS) Study Arch Intern Med. 2007;167(15): doi: /archinte Risk of death among patients with community-acquired pneumonia according to baseline characteristics and plasma cytokine concentrations. Results are from a Cox proportional hazards model for mortality. Point estimates are shown along with their 95% confidence intervals. While race and sex did not seem to contribute to the risk of death, age, comorbidity, and high concentrations of IL-6 (interleukin 6) or IL-10, even combined with low levels of the other cytokine, were associated with death. The combination of medium-level IL-6 and IL-10 also increased the risk of death severalfold, while high levels of both cytokines increased the risk of death by more than 20 times. Age indicates increase in age by 10 years; CCI, Charlson Comorbidity Index; in all low/medium/high concentration combinations, the first term designates IL-6 groups and the second term IL-10 groups, with low/low used as the referent for the hazard ratio of the rest. Figure Legend: